Indications and technical aspects of brachytherapy in breast conserving treatment of breast cancer

Cancer/Radiotherapie

Volumn 7, Issue 2, 2003, Pages 107-120

  Van Limbergen, Erik ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Brachytherapy; Breast cancer; Cosmesis; Local control; Localisation methods; Skin teleangiectasia

Indexed keywords

MIDAZOLAM MALEATE;

ARTICLE; BEAM THERAPY; BRACHYTHERAPY; BREAST CANCER; BREAST FIBROSIS; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; ELECTRON BEAM; HUMAN; INTERSTITIAL RADIATION; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTON; PRIORITY JOURNAL; RADIATION DOSE; TELANGIECTASIA; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0038416082     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(03)00015-5     Document Type: Article

References (56)

1. Arriagada R, Mouriesse H, Sarrazin D, Clark RM, Deboer G. Radiotherapy alone in breast cancer. I. Analysis of tumorsize, tumor dose and local control: the experience of the Gustave Roussy Institute and the Princess Margaret Hospital. Int J Radiat Oncol Biol Phys 1985;11:1751-7.
2. Bartelink H, Horiot JC, Poortmans PM, Struikmans H, Van den Bogaert W, Barillot, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001;345(19):1378-87.
3. Borger JH, Kemperman H, Smitt HS, Hart A, van Dongen J, Lebesque J, et al. Dose and volume effects on fibrosis after breast conservation therapy. Int J Radiat Oncol Biol Phys 1994;30(5):1073-81.
4. Calitchi E, Otmezguine Y, Feuilhade F, Piedbois P, Pavlovitch J, Brun B, et al. External irradiation prior to conservative surgery for breast cancer treatment. Int J Radiat Oncol Biol Phys 1991;21:325-9.
5. Clarke DH, Lé MG, Sarrazin D, Lacombe MJ, Fontaine F, Travagli JP, et al. Analysis of local regional relapses in patients with early breast cancers treated by excision and radiotherapy. Experience of the Institute Gustave Roussy. Int J Radiat Oncol Biol Phys 1985;11:137-45.
6. Collette L, Fourquet A, Horiot JC, Jager J, Peterse J, Pierart M, et al. Impact of a boost of 16 Gy on local control in patients with early breast cancer: the EORTC "boost versus no boost" trial. Radiother Oncol 2000;56(Suppl 1);S46 [Abstract 168].
7. de la Rochefordière A, Abner AL, Silver B, Vicini F, Recht A, Harris JR. Are cosmetic results following conservative surgery and radiation therapy for early breast cancer dependent on technique? Int J Radiat Oncol Biol Phys 1992;23(5):925-31.
8. Deore SM, Sarin R, Dingshaw K, Shrivastava SK. Influence of dose rate and dose per fraction on clinical outcome of breast cancer treated by external beam irradiation plus iridium-192 implants. Analysis of 289 cases. Int J Radiat Oncol Biol Phys 1993;26:601-6.
9. Dutreix A, Marinello G, Wambersie A. Dosimetrie en curiethérapie. Paris: Masson; 1982. p. 109-38.
10. Fentiman I, Poole C, Tong D, Winter P, Gregory W, Mayles H, et al. Inadequacy of iridium implant as a sole radiation treatment for operable breast cancer. Eur J Cancer 1996;32:608-11.
11. Fourquet A, Campana F, Mosseri V, Cetingoz R, Luciani S, Labib A, et al. Iridium 192 versus cobalt 60 boost in 3-7 cm breast cancer treated by irradiation alone: final results of a randomised trial. Radiother Oncol 1995;34:114-20.
12. Fowble B, Solin LJ, Martz KL. The influences of the type of boost (electrons vs. implant) on local control and cosmesis in patients with stages I and II breast cancer undergoing conservative surgery and radiation. Int J Radiat Oncol Biol Phys 1986;12:150 [abstract].
13. Fowler JF, Van Limbergen E. Biological effect of pulsed dose rate brachytherapy with stepping sources, if short half-times of repair are present in tissues. Int J Radiat Oncol Biol Phys 1997;37:877-83.
14. Fritz P, Berns C, Anton HW, Hensley F, Assman J, Flentje M, et al. PDR brachytherapy with flexible implants for interstitial boost after breast-conserving surgery and external beam radiation therapy. Radiother Oncol 1997;45(1):23-32.
15. Guedea F, Biete A, Craven-Bartle J, Alonso C, Ojeda B. External and interstitial radiation therapy of locally advanced carcinoma of the breast. Acta Oncol 1992;31:303-6.
16. Gump FE. Multicentricity in early breast cancer. Semin Surg Oncol 2001;177:330-7.
17. Habibollahi F, Mayles HM, Mayles WP, Winter P, Tong D, Fentiman IS, et al. Assessment of skin dose and its relation to cosmesis in the conservative treatment of early breast cancer. Int J Radiat Oncol Biol Phys 1988;14:291-6.
18. Hammer J, Seewald DH, Track C. Breast cancer: primary treatment with external-beam radiation therapyand high-dose-rate iridium implantation. Radiology 1994;193(2):573-7.
19. Hammer J, Track C, Seewald DH, Zoidl JP, Labeck W, Putz E, et al. Breast cancer: external beam radiotherapy and interstitial iridium implantation-10-year clinical results. EJC 1998;34(Suppl 1):32 [abstract].
20. Hammer J. What are the minimal requirements for boost target localisation? In: Hammer J, Van Limbergen E, editors. Breast cancer to boost or not to boost and how to do it. Consensus meeting on breast cancer (GEC-ESTRO Annual Meeting, Stresa. 2001.
21. Harrington KJ, Harrison M, Bayle P, Evans K, Dunn PA, Lambert HE, et al. Surgical clips in planning the electron boost in breast cancer: a qualitative and quantitative evaluation. Int J Radiat Oncol Biol Phys 1996;34:579-84.
22. Hennequin C, Durdux C, Espié M, Balla-Mekias S, Housset M, Marty M. High dose rate brachytherapy for early breast cancer: an ambulatory technique. Int J Radiat Oncol Biol Phys 1999;45:85-90.
23. Holland R, Veling SH, Mravunac M, Hendriks J. Histologic multifocality of Tis, T1 T2 breast carcinomas. Implications for clinical trials of breast conserving therapy. Cancer 1985;56:979-90.
24. Holland R, Conolly JL, Gelman R, Mravanac M, Hendriks J, Verbeek A, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990;8:113-8.
25. Johanson B, Karlsson L, Liljegren G. PDR brachytherapyas the sole adjuvant radiotherapy after breast conserving surgery of T1-2 breast cancer. Program and abstracts. 10th International Brachytherapy Conference. Madrid: Nucletron; 2000. p. 127 [Abstract].
26. Kuske RR, Bolton JS, McKinnon MP, Scroggins TG, Zakris EL, Wilenzick RW. 6.5-year results of a prospective phase II trial of wide volume brachytherapy as the sole method of breast irradiation in Tis, T1, T2, No1 breast cancer. Radiother Oncol 2000;55(Suppl 1):2 [Abstract].
27. Machtay M, Lanciano R, Hoffman J, Hanks G. Inaccuracies in using the lumpectomy scar for planning electron boosts in primary breast carcinoma. Int J Radiat Oncol Biol Phys 1994;30:43-8.
28. Mangold CA, Rijnders A, Georg D, Van Limbergen E, Potter R, Huyskens D. Quality control in interstitial brachytherapy of the breast using pulsed dose rate: treatment planning and dose delivery with an Ir-192 after loading system ea. Radiother Oncol 2001;58:43-51.
29. Mansfield CM, Komarnicky LT, Schwartz GF, Rosenberg A, Krishnan L, Jewill W, et al. Ten year results in 1070 patients with stages I and II breast cancer treated by conservative surgeryand radiation therapy. Cancer 1995;75:2328-36.
30. Mazeron JJ, Simon JM, Crook J, Calitchi E, Otnezguine Y, Le Bourgeois J, et al. Influence of dose rates on local control of breast carcinoma treated by external beam irradiation plus iridium implant. Int J Radiat Oncol Biol Phys 1991;21:1173-7.
31. McRae D, Rodgers J, Dritschilo A. Dose-volume and complication in interstitial implants for breast carcinoma. Int J Radiat Oncol Biol Phys 1987;13:525-9.
32. Olivotto IA, Rose MA, Osteen RT, Love S, Cady B, Silver B, et al. Late cosmetic outcome after conservative surgeryand radiotherapy: analysis of causes of cosmetic failure. Int J Radiat Oncol Biol Phys 1989;17:747-53.
33. Perera F, Chisela F, Engel, Venkatesan V. Method of localisation and implantation of the lumpectomy cavity for high dose rate brachytherapy after conservative surgery for T1 and T2 breast cancer. Int J Radiat Oncol Biol Phys 1995;31:4959-66.
34. Perez CA, Taylor ME, Halverson K, Garcia D, Kuske R, Lockett M. Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast; a non-randomised comparison. Int J Radiat Oncol Biol Phys 1996;34:995-1007.
35. Pierquin B, Huart J, Raynal M, Otmezguine Y, Calitchi E, Mazeron JJ, et al. Conservative treatment for breast cancer: long term results (15 years). Radiother Oncol 1991;20:16-23.
36. Polgar C, Major T, Mangel L, Takacsi-Nagy Z, Somogyi A. Sole brachytherapy after breast conserving surgery: 4-years results of a pilot studyand initial findings of a randomised Phase III trial. Radiother Oncol 2000;55(Suppl 1):31 [abstract].
37. Polgar C, Orosz Z, Fodor J, Fodor J, Sulyok Z, Toth J, et al. The effect of high-dose rate brachytherapy and electron boost on local control and side effects after breast conserving surgery: first results of the randomized Budapest breast boost trial. Radiother Oncol 2001;60(Suppl 1):10 [abstract].
38. Ray GR, Fish VJ. Biopsy and definitive radiation therapy in stage I and II adenocarcinoma of the female breast: analysis of cosmesis and the role of electron beam supplementation. Int J Radiat Oncol Biol Phys 1983;9:813-8.
39. Recht A, Silver B, Schnitt SJ, Connolly JL, Hellman S, Harris JR. Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage. Int J Radiat Oncol Biol Phys 1985;11:1271-6.
40. Romestaing P, Lehingue Y, Carrie C, Coquard R, Ardiet J, Mornex F, et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomised clinical trial in Lyon, France. J Clin Oncol 1997;15:963-8.
41. Sarin R, Dinshaw KA, Shrivastava SK, Sharma V, Deore SM. Therapeutic factors influencing the cosmetic outcome and late complications in the conservative management of early breast cancer. Int J Radiat Oncol Biol Phys 1993;27:282-5.
42. Sedlmayer F, Rahim H, Kogelnik H, Menzel C, Merz F, Deutschmann H, et al. Quality assurance in breast cancer brachytherapy: geografic miss in the interstitial boost treatment of the tumourbed. Int J Radiat Oncol Biol Phys 1996;34:1133-9.
43. Solin LJ. A practical technique for the localisation of the tumor volume in definitive irradiation of the breast. Int J Radiat Oncol Biol Phys 1985;11:1215-20.
44. Taylor ME, Perez CA, Halverson KJ, Kuske RR, Philpott GW, Garcia D, et al. Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys 1995;31:753-64.
45. Tessier E, Hery M, Lagrange JL. Boost in conservative treatment: 6 years results of a randomized trial. Breast Cancer Res Treatment 1998;50:3:245.
46. Touboul E, Belkacemi Y, Lefranc JP, Uzan S, Ozsahin M, Korbas D, et al. Early breast cancer: influence of type of boost (electrons vs iridium-192 implant) on local control and cosmesis after conservative surgery and radiation therapy. Radiother Oncol 1995;34(2):105-13.
47. Turesson I, Notter G. The influence of fraction size in radiotherapy on the late normal tissue reaction (I + II). Int J Radiother Oncol Biol Phys 1984;10:593-606.
48. Van Limbergen E, Van den Bogaert W, Van der Schueren E, Rijnders A. Tumour excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control. Radiother Oncol 1987;8:1-9.
49. Van Limbergen E, Rijnders A, Van der Schueren E, Lerut A, Christiaens R. Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results. Radiother Oncol 1989;16:253-67.
50. Van Limbergen E, Briot E, Drijkoningen M. The skin-source measuring bridge. A method to avoid radiation teleangiectasia in the skin after interstitial implants for breast cancer. Int J Radiat Oncol Biol Phys 1990;18:1239-44.
51. Van Limbergen E, Van der Schueren E, Van den Bogaert W, Van Wing J. Local control of operable breast cancer with radiotherapy-only. Eur J Cancer 1990;26:674-9.
52. Van Limbergen E, Rijnders A, Van den Bogaert W. The useful boost range concept judges the ballistic selectivity of electron beams versus brachytherapy in the boost techniques of breast conserving therapy. Eur J Cancer 1998;34(Suppl 5):S57.
53. Van Limbergen E, Pescova-Georg P. The source-skin distance measuring bridge (SSMB) reduces indeed skin teleangiectasia after interstitial boost in breast conserving therapy (BCT) for breast cancer: 15 years of clinical experience. Radiother Oncol 2000;55(Suppl 1):32.
54. Vicini F, Kini VR, Chen P. Brachytherapy of the tumour bed alone after lumpectomy in selected patients with early stage breast cancer treated with breast conserving therapy. J Surg Oncol 1999;70:30-40.
55. Vrieling C, Colette L, Fourquet A, Hoogenraad W, Horiot J, Jager J, et al. The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the RORTC 'boost vs no boost' trial. Radiother Oncol 2000;55:219-32.
56. Wazer DE, Kramer B, Schmid C, Ruthazer R, Ulin K, Schmidt Ullrich R. Factors determining outcome in patients treated with interstitial implantation as a radiation boost for breast conservation therapy. Int J Radiat Oncol Biol Phys 1997(2):381-93 39.